Concord, CA, United States of America

Deqian Wang

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2009-2016

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Deqian Wang: Innovator in Factor VIII Conjugates

Introduction

Deqian Wang is a prominent inventor based in Concord, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of Factor VIII conjugates. With a total of 6 patents to his name, Wang's work has had a substantial impact on medical science.

Latest Patents

Wang's latest patents focus on Factor VIII muteins that are covalently bound to biocompatible polymers such as polyethylene glycol. These inventions retain FVIII procoagulant activity while improving pharmacokinetic properties. His innovative approach to Factor VIII conjugates represents a significant advancement in therapeutic applications.

Career Highlights

Throughout his career, Deqian Wang has worked with notable companies, including Bayer Healthcare LLC and Bayer Technology Services GmbH. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the field.

Collaborations

Wang has collaborated with esteemed colleagues, including Clark Qun Pan and John E. Murphy. These partnerships have fostered a collaborative environment that has led to innovative solutions in biotechnology.

Conclusion

Deqian Wang's contributions to the field of biotechnology, particularly through his patents on Factor VIII conjugates, highlight his role as a leading inventor. His work continues to influence advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…